Most Likely Etiologies
The combination of cleft palate, cerebellar hypoplasia, and absent cavum septum pellucidum on fetal ultrasound should prompt immediate consideration of 22q11.2 deletion syndrome (DiGeorge syndrome) as the primary diagnosis, followed by evaluation for disruptive brain injuries and rare genetic syndromes.
Primary Differential Diagnosis
22q11.2 Deletion Syndrome (DiGeorge Syndrome)
This is the most critical diagnosis to consider given the constellation of findings:
- Palatal abnormalities occur in approximately two-thirds of affected children, including overt cleft palate 1
- Absent cavum septum pellucidum is specifically listed as a prenatal indicator of 22q11.2DS 1
- Cerebellar dysgenesis is recognized as a less frequent but significant manifestation contributing to substantial morbidity 1
The syndrome also commonly presents with:
- Conotruncal cardiac defects (present in ~67% of cases) 1
- Thymic abnormalities
- Characteristic dysmorphic features
Recommended action: Obtain chromosomal microarray analysis and/or targeted FISH testing for 22q11.2 deletion immediately. Consider fetal echocardiography to evaluate for associated cardiac defects, which would further support this diagnosis 1.
Disruptive Brain Lesions
The second major category to consider involves vascular or infectious disruptions during fetal development 2:
- Disruptive events (ischemia, hemorrhage, infections like CMV, placental insufficiency) can cause:
- Polymicrogyria
- Cerebellar hypoplasia
- Septo-optic dysplasia with absent septum pellucidum
- Dandy-Walker malformation 2
Key distinguishing features to assess:
- Maternal history of fever, rash, or illness during pregnancy
- Evidence of intracranial calcifications on imaging (suggests CMV)
- White matter injury or cysts
- Gliosis patterns 3
- Asymmetric or focal nature of brain injury
Recommended action: Obtain maternal serologies for TORCH infections (particularly CMV and toxoplasmosis). Review detailed perinatal history for teratogen exposure (alcohol, cocaine, medications) 3, 2.
Septo-Optic Dysplasia (SOD)
This should be considered when absent septum pellucidum is identified 4, 5:
- Can present with isolated absent septum pellucidum prenatally
- May not manifest full clinical picture (optic nerve hypoplasia, pituitary dysfunction) until postnatal period
- In one series, 11.7% of fetuses with prenatally isolated absent septum pellucidum were later confirmed to have SOD 4
Critical caveat: Approximately 27.5% of cases classified as "isolated" absent septum pellucidum prenatally are reclassified after fetal MRI or postnatal evaluation 4. The addition of cleft palate and cerebellar hypoplasia makes isolated SOD less likely but still possible.
Rare Genetic Syndromes
Autosomal recessive porencephaly syndrome 6:
- Bilateral porencephaly with absent septum pellucidum
- Pancerebellar hypoplasia including vermis absence
- Associated cardiac defects (tetralogy of Fallot, ASD)
- Extremely rare; consider if family history suggests consanguinity or affected siblings
Other considerations:
- EFTUD2 haploinsufficiency (mandibulofacial dysostosis with microcephaly) can present with microcephaly and mandibular hypoplasia but typically not with this specific triad 7
- Isolated palatoglossal fusion with cerebellar vermis hypoplasia has been reported but is exceedingly rare 8
Diagnostic Algorithm
Step 1: Genetic Testing
- Chromosomal microarray analysis (priority for 22q11.2 deletion)
- If negative and phenotype supports, proceed to exome sequencing
Step 2: Infectious Workup
- Maternal CMV IgM/IgG with avidity testing
- Toxoplasmosis serologies
- Consider amniocentesis for CMV PCR if maternal serologies suggest acute infection
Step 3: Advanced Imaging
- Fetal MRI to better characterize:
- Extent and pattern of cerebellar hypoplasia
- Presence of calcifications, hemorrhage, or white matter injury
- Associated corpus callosum abnormalities
- Optic nerve anatomy (for SOD evaluation)
Step 4: Cardiac Evaluation
- Detailed fetal echocardiography (essential given high prevalence of conotruncal defects in 22q11.2DS)
Step 5: Detailed Anatomic Survey
- Thymic assessment (absent/hypoplastic thymus supports 22q11.2DS)
- Renal anomalies
- Skeletal survey for vertebral or limb anomalies
- Growth parameters and polyhydramnios assessment
Critical Pitfalls to Avoid
Do not assume isolated absent septum pellucidum: Up to 72.5% of cases initially classified as isolated are reclassified after comprehensive evaluation 4
Do not delay genetic testing: 22q11.2 deletion syndrome has significant implications for pregnancy management, delivery planning, and immediate postnatal care (cardiac surgery, immune deficiency management) 1
Do not overlook infectious etiologies: A negative initial maternal history does not exclude congenital infection; many CMV infections are asymptomatic in mothers 3, 2
Do not provide definitive prognosis without complete evaluation: The prognosis varies dramatically depending on etiology—from relatively favorable in isolated absent septum pellucidum to severe neurodevelopmental impairment in 22q11.2DS or disruptive injuries 4, 9
Counseling Considerations
If 22q11.2 deletion confirmed:
- High risk for cardiac surgery in infancy with increased perioperative complications 1
- Palatal repair typically required around age 1 year 1
- Significant risk of developmental delay, cognitive deficits, and psychiatric disorders emerging in childhood/adolescence 1
- Lifelong multidisciplinary care required across 10+ subspecialties 1
If disruptive etiology confirmed:
- Generally low recurrence risk (typically <1% unless underlying maternal condition persists) 2
- Neurodevelopmental outcome depends on extent and timing of injury
- Prognosis most favorable when disruption is limited and occurs later in gestation
If no etiology identified: